|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Crystal structure and its correlation to intrinsic and extrinsic magnetic properties of epitaxial hard magnetic Pr-Co films显示文摘 | Parra A.K Neu V F(a)hler S Groetzschel R Bedanta S Kleemann W and Schultz L | | 0，，18： | 1 |
| 2 | Efficient organic solvent and oil sorbent co-polyesters: Poly-9-octadecenylacrylate/methacrylate with 1-hexene显示文摘 | Priyanka Dutta Bedanta Gogoi NarendraNath Dass Neelotpal Sen Sarma | 2012 | Reactive and Functional Polymers2012，，： | 1 |
| 3 | Study of magnetization reversal processes in a thin Co film显示文摘 | N. Chowdhury S. Bedanta G.S. Babu | 2013 | Journal of Magnetism and Magnetic Materials2013，，： | 1 |
| 4 | Prevention of Ventilator-Associated Pneumonia and Ventilator-Associated Conditions显示文摘 | Shakti Bedanta Mishra Afzal Azim Syed Nabeel Muzzafar | 2015 | Critical Care Medicine2015，，： | 1 |
| 5 | Drosophila melanogaster as an indispensable model to decipher the mode of action of neurotoxic compounds显示文摘Exposure to some toxic compounds causes structural and behavioral anomalies associated with the neurons in the later stage of life.Those toxic compounds are termed as a neurotoxicant,which can be a physical factor,a toxin,an infection,radiation,or maybe a drug.The incongruities caused due to a neurotoxicant further depend on the toxicity of the compound.More importantly,the neurotoxicity of the compound is associated with the concentration and the time point of exposure.The neurodevelopmental defect appears depending on the toxicity of the compound.A neurodevelopmental defect may be associated with a delay in developmental time,defective growth,structural abnormality of many organs,including sensory organs,behavioral abnormalities,or death in the fetus stage.Numerous model organisms are employed to assess the effect of neurotoxicants.The current review summarizes several methods used to check the effect of neurotoxicant and their effect using the model organism Drosophila melanogaster. | MONALISA MISHRA PUNYATOYA PANDA BEDANTA KUMAR BARIK AMRITA MONDAL MRUTUNJAYA PANDA | 2023 | BIOCELL2023，47，1： | 0 |
| 6 | Phytochemical Loaded Nanovehicles of Biopolymer for Breast Cancer:A Systemic Review显示文摘Background:Breast cancer is one of the most common malignancies affecting women worldwide,emphasizing the need for effective therapeutic strategies.Phytochemicals derived from plants have gained significant attention due to their potential anticancer properties.Objective:This review aims to comprehensively assess the existing literature on using phytochemical-loaded for-mulations as a therapeutic approach for breast cancer.By analyzing the available evidence,we aim to determine the potential benefits and limitations of these formulations in terms of their anticancer activity,bioavailability,and safety.Methods:A systematic search of relevant databases was conducted to identify studies investigating phytochemical-loaded formulations in the context of breast cancer treatment.The inclusion criteria encompassed clinical trials,preclinical studies,and in-vitro experiments that reported using phytochemicals in various formulations for breast cancer treatment.Data extraction was performed to ensure the reliability and validity of the included studies.Results:The review highlights the diverse range of phytochemicals used in different formulations for breast cancer treatment.Findings suggest that these formulations exhibit promising anticancer effects by targeting mul-tiple signaling pathways in breast cancer progression,including cell proliferation,apoptosis,angiogenesis,and metastasis.Moreover,various delivery systems,such as nanoparticles,liposomes,and micelles,have enhanced phytochemicals’bioavailability and targeted delivery.Conclusion:Phytochemical-loaded formulations hold immense potential as a therapeutic approach for breast cancer treatment.The reviewed evidence indicates their ability to inhibit tumor growth,enhance chemotherapy effectiveness,and reduce adverse effects.However,further research is warranted to optimize the formulation strategies,investigate the long-term safety profiles,and conduct large-scale clinical trials to establish their efficacy and applicability in clinical settings.These findings contribute to developing novel phytochemical-based therapies for breast cancer,offering new avenues for personalized and targeted treatment options. | Vivek P.Chavda Suneetha Vuppu Rajashri Bezbaruah Lakshmi Vineela Nalla Siva Nageswara Rao Gajula Pankti C.Balar Toshika Mishra Nikita Sharma Sathvika Kamaraj Thushar Suresh Anand Sairam Bedanta Bhattacharjee | 2023 | Clinical Complementary Medicine and Pharmacology2023，3，4： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员